Niagen Bioscience (NAGE) Debt to Equity Ratio: 0.025

Niagen Bioscience, Inc. (NAGE)

2.15 -0.13 (-5.70%) USD | NASDAQ | Nov 10, 16:00

2.14 -0.01 (-0.47%) After-Hours: 20:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2007. Start Trial.

Date	Value
September 30, 2026	0.025
June 30, 2026	0.0282
March 31, 2026	0.0313
December 31, 2025	0.0368
September 30, 2025	0.0432
June 30, 2025	0.0513
March 31, 2025	0.0637
December 31, 2024	0.0575
September 30, 2024	0.0842
June 30, 2024	0.1017
March 31, 2024	0.1114
December 31, 2023	0.1152
September 30, 2023	0.1388
June 30, 2023	0.1451
March 31, 2023	0.1459
December 31, 2022	0.1485
September 30, 2022	0.2084
June 30, 2022	0.2185
March 31, 2022	0.1801
December 31, 2021	0.1482
September 30, 2021	0.0944
June 30, 2021	0.0833
March 31, 2021	0.0335
December 31, 2020	0.0997
September 30, 2020	0.0937

Date	Value
June 30, 2020	0.0609
March 31, 2020	0.0932
December 31, 2019	0.0841
September 30, 2019	0.0738
June 30, 2019	0.8098
March 31, 2019	0.1086
December 31, 2018	0.0114
September 30, 2018	0.0108
June 30, 2018	0.0101
March 31, 2018	0.0098
December 31, 2017	0.0094
September 30, 2017	0.0163
June 30, 2017	0.0269
March 31, 2017	0.0684
December 31, 2016	0.0601
September 30, 2016	0.0422
June 30, 2016	0.0447
March 31, 2016	0.8387
December 31, 2015	1.05
September 30, 2015	1.278
June 30, 2015	1.423
March 31, 2015	0.8311
December 31, 2014	0.7161
September 30, 2014	0.1376
June 30, 2014	0.1305

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks